Obesity Surgery

, Volume 25, Issue 1, pp 1–6

Predicting Remission of Diabetes After RYGB Surgery Following Intensive Management to Optimize Preoperative Glucose Control

  • Thomas MacAndrew English
  • Samir Malkani
  • Rebecca L. Kinney
  • Abdulkadir Omer
  • Mary Beth Dziewietin
  • Richard Perugini
Original Contributions



The purpose of the study is to investigate the association of preoperative glucose optimization prior to a Roux-en-Y gastric bypass (RYGB) and diabetes remission.


The study is a retrospective review of 245 patients with a history of diabetes type II and a RYGB from 2008 to 2012 at UMass Memorial Hospital.


Patients that benefited from glucose optimization prior to RYGB were more likely to achieve diabetes remission 1 year after surgery. The preoperative glucose optimization intervention demonstrated that when patients decreased their HbA1c prior to surgery by 1 %, these individuals were 68 % more likely to remit (p = 0.015). Duration of diabetes (p = 0.005) and insulin use (p < 0.001) were also significant predictors of remission, whereas age, race, and gender were not.


Our study results indicate that a greater degree of glycemic improvement in response to presurgical medical intervention is associated with higher rates of diabetes remission post-operatively among obese adults with diabetes type II. Conversely, the lack of favorable glycemic response to intensification of medical management predicts a poor glycemic response to bariatric surgery. Further research is needed to determine if this difference is due to physiological factors or is simply an indicator of patient behavior.


Diabetes Gastric bypass Remission Glucose optimization Medical intervention 


  1. 1.
    Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. PMCID: 3372918.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.PubMedCrossRefGoogle Scholar
  3. 3.
    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56. e5.PubMedCrossRefGoogle Scholar
  4. 4.
    Hamza N, Abbas MH, Darwish A, et al. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis. 2011;7(6):691–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84. discussion 84-5. PMCID: 1360104.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013;36(1):20–6. PMCID: 3526207.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Huang CK, Shabbir A, Lo CH, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg. 2011;21(9):1344–9. PMCID: 3157602.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Lee WJ, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012;16(1):45–51. discussion -2.PubMedCrossRefGoogle Scholar
  9. 9.
    Still CD, Wood GC, Chu X, Manney C, Strodel W, Petrick A, et al. Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2013Google Scholar
  10. 10.
    Hayes MT, Hunt LA, Foo J, et al. A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg. 2011;21(7):910–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus Intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014.Google Scholar
  12. 12.
    CDC. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Atlanta, GA 2007 [updated 2007 cited 2013 June]; Available from: http://www.cdc.gov/features/dsdiabetes/.
  13. 13.
    Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175–82. PMCID: 3714483.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240–9. PMCID: 3954742.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Arterburn D, Bogart A, Coleman KJ, et al. Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013;7(4):e258–68.PubMedCrossRefGoogle Scholar
  16. 16.
    Dirksen C, Jacobsen SH, Bojsen-Moller KN, et al. Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report. Obes Res Clin Pract. 2013;7(4):e269–74.PubMedCrossRefGoogle Scholar
  17. 17.
    Cheskin LJ, Kahan SACP, Club J. Review: bariatric surgery increases weight loss and diabetes remission more than nonsurgical treatment. Ann Intern Med. 2014;160(2):JC7.PubMedCrossRefGoogle Scholar
  18. 18.
    Brandenburg D, Kotlowski R. Practice makes perfect? Patient response to a prebariatric surgery behavior modification program. Obes Surg. 2005;15(1):125–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Dolfing JG, Dubois EF, Wolffenbuttel BH, et al. Different cycle ergometer outcomes in severely obese men and women without documented cardiopulmonary morbidities before bariatric surgery. Chest. 2005;128(1):256–62.PubMedCrossRefGoogle Scholar
  20. 20.
    Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3(2):141–5. discussion 5-6.PubMedCrossRefGoogle Scholar
  21. 21.
    Kalarchian MA, Marcus MD, Courcoulas AP, et al. Preoperative lifestyle intervention in bariatric surgery: initial results from a randomized, controlled trial. Obesity (Silver Spring). 2013;21(2):254–60. PMCID: 3610845.CrossRefGoogle Scholar
  22. 22.
    Tarnoff M, Kaplan LM, Shikora S. An evidenced-based assessment of preoperative weight loss in bariatric surgery. Obes Surg. 2008;18(9):1059–61.PubMedCrossRefGoogle Scholar
  23. 23.
    Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(7):2479–85. PMCID: 2453054.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Lingvay I, Guth E, Islam A, et al. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care. 2013;36(9):2741–7. PMCID: 3747905.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg. 2010;14(1):15–23. PMCID: 2793380.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Lin E, Davis SS, Srinivasan J, et al. Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass. Am Surg. 2009;75(6):498–502. discussion -3. PMCID: 3068861.PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Thomas MacAndrew English
    • 1
  • Samir Malkani
    • 2
  • Rebecca L. Kinney
    • 1
  • Abdulkadir Omer
    • 3
  • Mary Beth Dziewietin
    • 1
  • Richard Perugini
    • 4
  1. 1.Department of Quantitative Health SciencesUniversity of Massachusetts Medical SchoolWorcesterUSA
  2. 2.Diabetes Center of ExcellenceUniversity of Massachusetts Medical SchoolWorcesterUSA
  3. 3.EndocrinologyUniversity of Massachusetts Medical SchoolWorcesterUSA
  4. 4.Department of SurgeryUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations